Duane Reade
Pharmacy
11 Edgewater Towne Ctr, Edgewater
New Jersey, 07020
201-941-2050 Duane Reade is a Pharmacy in Edgewater, New Jersey. This organization is also known as sub part of Walgreens Boots Alliance Inc. It is located at 11 Edgewater Towne Ctr, Edgewater and it's customer support contact number is 201-941-2050. The authorized person of Duane Reade is Alyssa Sweeten who is Manager of the pharmacy and his contact number is 217-709-2386. Active license number of Duane Reade is 28RS00592400 for Pharmacy in New Jersey. Duane Reade accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Duane Reade is a facility used by pharmacists for the compounding and dispensing of medicinal preparations and other associated professional and administrative services. A pharmacy is a facility whose primary function is to store, prepare and legally dispense prescription drugs under the professional supervision of a licensed pharmacist. It meets any licensing or certification standards set forth by the jurisdiction where it is located.
Pharmacy Details:
Duane Reade type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Duane Reade |
| Type: | Pharmacy |
| Location: | 11 Edgewater Towne Ctr, Edgewater,
New Jersey, 07020 |
| Phone: | 201-941-2050 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Alyssa Sweeten |
| Position: | Manager |
| Contact Number: | 217-709-2386 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1851316319 |
| Parent Organization: | Walgreens Boots Alliance Inc |
| NPI Enumeration Date: | 13 Jul, 2006 |
| NPI Last Update On: | 27 Aug, 2018 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Duane Reade are as mentioned below.
| Specialization | License Number | State | Status | |
| Pharmacy | 28RS00592400 | New Jersey | Primary | |
| Durable Medical Equipment & Medical Supplies | | | Secondary | |
| Community/Retail Pharmacy | | | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 3142623 | Other | | Other Id Number-commercial Number |
| 8555109 | Medicaid | New Jersey | |
Medicare Enrollment:
Duane Reade is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 3971644642 | O20100930098957 | Duane Reade | DME SUPPLIER - PHARMACY |
Products Available:
Duane Reade has following products available for sale under medicare.
| Products: |
|---|
| • Blood Glucose Monitors & Supplies: Non-mail Order | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 1901 E Voorhees St, M/s 790
Danville, Illinois |
| Zip: | 61834-4509 |
| Phone Number: | 217-709-2386 |
| Fax Number: | 217-709-2344 |
Patients can reach Duane Reade at
11 Edgewater Towne Ctr, Edgewater, New Jersey or can
call on customer care at 201-941-2050.
Comments/ Reviews:
Read all the reviews posted for Duane Reade below. You may also share your own experience with Duane Reade. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.